Dr. Alan Bauman calls attention to its clinically backed BOOST DHT-Control Shampoo & Conditioner Kit. The upgraded system represents an evolution of the brand’s existing best-selling hair care system. It targets consumer concern of thinning hair with dihydrotestosterone (DHT) blockers — compounds known to help maintain follicle health.
Now positioned with a greater emphasis on concentrated ingredients and ethical formulation, the BOOST DHT-Control Shampoo & Conditioner Kit introduces a higher concentration of DHT-blocking agents alongside an enhanced blend of botanicals, all while adhering to vegan and cruelty-free standards. From saw palmetto and green tea extract to rosemary oil and peppermint oil, these naturally derived ingredients work to support hair vitality and enhance olfactory sensations.
The haircare formulations work in tandem to purify the scalp without causing heaviness
Image Credit: Dr. Alan Bauman
Key Themes Behind This Trend
- Concentrated Dht-blocking Formulations
- Higher-potency topical blends create opportunities for novel delivery mechanisms and dosing profiles that could extend follicle exposure while minimizing systemic absorption.
- Ethical High-performance Botanicals
- A shift toward vegan, cruelty-free botanicals opens possibilities for traceable, sustainably sourced ingredient streams that reinforce efficacy claims and brand trust.
- Scalp-purifying Lightweight Systems
- Formulations that balance deep cleansing with non-heavy conditioning suggest scope for microbiome-friendly, low-residue products tailored to oily or thinning scalps.
Where This Applies
- Dermatology and Trichology
- Clinical practices could integrate higher-concentration topical options with diagnostic scalp profiling to stratify patients and refine treatment paths.
- Haircare Retail and Dtc
- Direct-to-consumer brands are positioned to combine product efficacy narratives with personalized sampling and subscription models that emphasize repeatable results.
- Cosmeceuticals and Nutraceuticals
- Blurring lines between topical actives and ingestible supports creates room for combined regimens that target DHT modulation from multiple biological angles.
